Heavy menstrual bleeding: a global survey of health care practitioners’ perceptions-Reference-Cited by-同舟云学术

Heavy menstrual bleeding: a global survey of health care practitioners’ perceptions

Published:2018-06-25 Issue:4 Volume:23 Page:288-294
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Lunardi Rocha Ana Luiza¹,Cristina França Ferreira Márcia¹,Mara Lamaita Rívia¹,Batista Cândido Eduardo¹,Mendonça Carneiro Márcia¹,Lopes da Silva-Filho Agnaldo¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynaecology, Federal University of Minas Gerais, Belo Horizonte, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2018.1483018

Reference24 articles.

1. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial

2. Choice of primary outcomes evaluating treatment for heavy menstrual bleeding

3. Hemoglobin levels predict quality of life in women with heavy menstrual bleeding

4. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations;The European Journal of Contraception & Reproductive Health Care;2022-09-02

2. Relevance of abnormal uterine bleeding issue in young women and its comprehensive solution considering 2021 Russian Guidelines;Gynecology;2022-07-09

3. The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey;The European Journal of Contraception & Reproductive Health Care;2021-05-28

4. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders;Contraception;2020-10